Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03356145 · ClinicalTrials.gov registry record · Phase 4
12 Versus 20 mL PCB for D&E Cervical Prep
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
NCT03356145: Completed Phase 4 study, sponsored by Stanford University.
NCT03356145 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03356145, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
Study Summary
More research is needed to investigate methods of pain control for cervical preparation for abortion procedures. Women report pain with paracervical block injection as well as with osmotic dilator placement. This study seeks to compare a 12 mL, 2-site 1% plain lidocaine paracervical block for pain control during cervical preparation (osmotic dilator insertion) for Dilation and Evacuation (D\&E) to a 20 mL 1% lidocaine 2-site paracervical block.
Interventions
- DRUG 12 mL paracervical block
- DRUG 20 mL paracervical block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2020-10-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03356145
The ClinicalTrials.gov registry entry for NCT03356145 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 12 mL paracervical block is the first listed.
NCT03356145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03356145 about?
NCT03356145 is a clinical study titled "12 Versus 20 mL PCB for D&E Cervical Prep". More research is needed to investigate methods of pain control for cervical preparation for abortion procedures. Women report pain with paracervical block injection as well as with osmotic dilator placement. This study seeks to compare a 12 mL, 2-site 1% plain lidocaine paracervical block for pain c...
What is the current status of trial NCT03356145?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2017-01-01. Estimated completion is 2020-10-15.
What interventions are being tested in trial NCT03356145?
The interventions under investigation include: 12 mL paracervical block (DRUG), 20 mL paracervical block (DRUG).
Who is sponsoring clinical trial NCT03356145?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.